Selected article for: "absorption bioavailability and low bioavailability"

Author: McCreary, Erin K; Pogue, Jason M
Title: Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
  • Document date: 2020_3_23
  • ID: j0i9ozsz_60
    Snippet: Anthelminthic drug with in vitro efficacy against SARS-CoV-1; however, low absorption and oral bioavailability resulting in a wide range of serum concentrations in healthy volunteers after a single dose may limit utility as antiviral treatment [63] ......
    Document: Anthelminthic drug with in vitro efficacy against SARS-CoV-1; however, low absorption and oral bioavailability resulting in a wide range of serum concentrations in healthy volunteers after a single dose may limit utility as antiviral treatment [63] .

    Search related documents:
    Co phrase search for related documents
    • anthelminthic drug and oral bioavailability: 1
    • anthelminthic drug and serum concentration: 1
    • antiviral treatment and healthy volunteer: 1
    • antiviral treatment and low absorption: 1
    • antiviral treatment and oral bioavailability: 1, 2, 3, 4
    • antiviral treatment and SARS vitro efficacy: 1
    • antiviral treatment and single dose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • antiviral treatment and utility limit: 1
    • antiviral treatment and vitro efficacy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • antiviral treatment and wide range: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • healthy volunteer and oral bioavailability: 1
    • healthy volunteer and single dose: 1
    • low absorption and oral bioavailability: 1, 2, 3, 4
    • low absorption and oral bioavailability low absorption: 1
    • low absorption and single dose: 1
    • low absorption and wide range: 1
    • oral bioavailability and serum concentration: 1
    • oral bioavailability and single dose: 1, 2, 3, 4, 5, 6
    • oral bioavailability and vitro efficacy: 1